Image

Genetic of Skeletal Muscle Insulin Resistance

Genetic of Skeletal Muscle Insulin Resistance

Recruiting
18-75 years
All
Phase N/A

We will seek to find the relationship between basal and insulin stimulated Quantitative trait loci (QTL's) by utilizing vastus lateralis muscle biopsies before and after a euglycemic/hyperinsulinemic clamp. Each volunteer will have a catheter placed into an antecubital vein for the infusion of all test substances. A second catheter will be inserted retrogradely into a vein on the dorsum of the hand, and the hand will be placed into a thermoregulated box heated to 45 to 50 degrees Celsius. All subjected will receive an infusion of [3-3H]glucose. After a 2-h basal tracer equilibration period, subjects will receive a prime-continuous insulin infusion at the rate of 80mU/m2*min. During the last 30 min of the basal equilibration period and throughout the insulin infusion, plasma samples will be taken at 5-10 min intervals for the determination of plasma glucose and insulin concentrations and tritiated glucose radioactivity. During the insulin infusion, a variable in-fusion of 20% glucose will be adjusted, based on the negative feedback principle, to maintain the plasma glucose concentration at ~100mg/dL with a coefficient of variation <5%. Skeletal muscle biopsies will be obtained from the vastus lateralis muscle approximately 1h prior to and at the end of the insulin clamp, and will be snap frozen in liquid nitrogen for nuclei isolation.

Study details
    Insulin Stimulated

NCT07780513

The University of Texas Health Science Center at San Antonio

23 August 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.